首页 | 本学科首页   官方微博 | 高级检索  
     

参麦注射液促进子宫切除术后骨骼肌功能恢复
引用本文:朱梅桢,潘亚飞,陈磊,王良荣,林丽娜. 参麦注射液促进子宫切除术后骨骼肌功能恢复[J]. 温州医科大学学报, 2021, 51(4): 315-318. DOI: 10.3969/j.issn.2095-9400.2021.04.012
作者姓名:朱梅桢  潘亚飞  陈磊  王良荣  林丽娜
作者单位:1.温州医科大学附属第一医院麻醉科,浙江温州325015;2.中国科学院基础医学与肿瘤研究所中国科学院大学附属肿瘤医院浙江省肿瘤医院麻醉科,浙江杭州310000
基金项目:温州市科技计划项目(Y20170659)。
摘    要:目的:观察参麦注射液预处理对腹腔镜子宫切除术患者腹腔引流液细胞因子及骨骼肌功能的影响。方法:将66例拟行腹腔镜下子宫切除术患者随机分为对照组(C组)和参麦组(SM组),SM组于切皮前静脉滴注参麦注射液0.6 mL/kg,C组给予等量0.9%氯化钠溶液。测定术前、术后4 h、术后1 d、术后2 d握力、肌耐力,以及腹腔引流液中炎症因子水平,评估术后恶心、呕吐等不良反应情况。结果:两组患者握力和肌耐力术后与术前比较均明显降低,SM组较C组各时间点降低幅度明显减小(P<0.01);术后4 h SM组腹腔引流液中IL-6和TNF-α水平均低于C组(P<0.05),引流液中IL-6水平与肌耐力呈负相关(P<0.05)。两组恶心、呕吐等不良反应发生率差异无统计学意义(P>0.05)。结论:参麦注射液0.6 mL/kg预处理可通过减少炎症因子的产生,促进腹腔镜子宫切除术后患者骨骼肌功能的恢复。

关 键 词:参麦注射液  子宫切除术  骨骼肌  IL-6  
收稿时间:2020-10-29

Promotion of romotes skeletal muscle function recovery in hysterectomy patients by Shenmai injection
ZHU Meizhen,PAN Yafei,CHEN Lei,WANG Liangrong,LIN Li’na. Promotion of romotes skeletal muscle function recovery in hysterectomy patients by Shenmai injection[J]. JOURNAL OF WENZHOU MEDICAL UNIVERSITY, 2021, 51(4): 315-318. DOI: 10.3969/j.issn.2095-9400.2021.04.012
Authors:ZHU Meizhen  PAN Yafei  CHEN Lei  WANG Liangrong  LIN Li’na
Affiliation:1.Department of Anesthesiology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China; 2.Department of Anesthesiology, Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou 310000, China
Abstract:Objective: To investigate the effect of Shenmai injection pretreatment on the levels of cytokines in abdominal drainage and skeletal muscle function in patients undergoing laparoscopic hysterectomy. Methods: Sixty-six patients undergoing laparoscopic hysterectomy were randomly divided as the control group (C group) and the Shenmai group (SM group). The patients in SM group received intravenous administration of Shenmai injection 0.6 mL/kg before skin incision, while the same amount of saline was given instead in C Group. The grip strength, muscle endurance, and inflammatory cytokines levels in abdominal drainage fluid were measured before surgery as baselines and 4 h, 1, 2 days post-operation as well. The occurrence of nausea, vomiting and other adverse events were also documented. Results: Compared with C group, the declines in grip strength and muscle endurance in SM group were significantly attenuated in each time point (P<0.05). However, grip strength and muscle endurance were decreased in both groups, compared with baseline values (P<0.05). The levels of IL-6 and TNF-α in the abdominal drainage fluid of SM group at 4 hours post-operation were significantly lower than those of group C (P<0.05), and the level of IL-6 in the drainage fluid was negatively correlated with grip work (P<0.05). There was no significant difference in adverse events between the the groups (P>0.05). Conclusion: Pretreatment with Shenmai injection 0.6 mL/kg could reduce the production of inflammatory cytokines and thus promote the recovery of skeletal muscle function in patients undergoing laparoscopic hysterectomy.
Keywords:Shenmai injection   laparoscopic hysterectomy   skeletal muscle  IL-6  
点击此处可从《温州医科大学学报》浏览原始摘要信息
点击此处可从《温州医科大学学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号